Significantly, a pioneering study on Tks5 in human cancer found a clinical prognostic relevance in glial-derived brain tumors [14] and prostate cancer [16], and a recent study defined the importance of a high ratio of Tks5α to Tks5β mRNAs in lung cancer [15]. The gene discussed is SH3PXD2A; the disease is prostate carcinoma.